Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1983 2
1984 2
1985 5
1986 1
1988 3
1989 1
1990 1
1991 2
1993 2
1994 2
1995 6
1996 4
1997 5
1998 3
1999 1
2000 2
2001 2
2002 3
2003 1
2004 5
2005 2
2006 2
2007 3
2008 1
2009 2
2010 5
2011 2
2012 3
2013 3
2014 5
2015 3
2016 5
2017 5
2018 5
2019 2
2020 5
2021 7
2022 4
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

114 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Cutaneous Chronic Lymphocytic Leukemia"
Page 1
Morphologic Diversity of Merkel Cell Carcinoma.
Ogawa T, Donizy P, Wu CL, Cornejo KM, Ryś J, Hoang MP. Ogawa T, et al. Am J Dermatopathol. 2020 Sep;42(9):629-640. doi: 10.1097/DAD.0000000000001548. Am J Dermatopathol. 2020. PMID: 32833736 Review.
Merkel cell carcinoma (MCC) is a rare and highly aggressive neuroendocrine carcinoma of unknown origin. We performed a retrospective histologic review of primary cutaneous MCCs diagnosed from 1997 to 2018 in several clinical institutions and literature review to determine …
Merkel cell carcinoma (MCC) is a rare and highly aggressive neuroendocrine carcinoma of unknown origin. We performed a retrospective histolo …
Leukemia Cutis as an Early Presentation or Relapsing Manifestation of Chronic Lymphocytic Leukemia (CLL).
Aldapt MB, Yassin M. Aldapt MB, et al. Acta Biomed. 2021 May 12;92(2):e2021192. doi: 10.23750/abm.v92i2.10763. Acta Biomed. 2021. PMID: 33988158 Free PMC article. Review.
BACKGROUND AND OBJECTIVE: Cutaneous infiltration by Chronic Lymphocytic Leukemia (CLL) is a rare complication. ...All patients 60 years had an early-stage disease, on the other hand, all patients with advanced-stage were >60 years. CONCLUSION: Patie …
BACKGROUND AND OBJECTIVE: Cutaneous infiltration by Chronic Lymphocytic Leukemia (CLL) is a rare complication. . …
Skin lesions in chronic lymphocytic leukemia.
Robak E, Robak T. Robak E, et al. Leuk Lymphoma. 2007 May;48(5):855-65. doi: 10.1080/10428190601137336. Leuk Lymphoma. 2007. PMID: 17487727 Review.
Cutaneous lesions occur in up to 25% of patients with chronic lymphocytic leukemia (CLL). These can be caused by either cutaneous seeding by leukemic cells (leukemia cutis, LC) and other malignant diseases or nonmalignant disorders. ...
Cutaneous lesions occur in up to 25% of patients with chronic lymphocytic leukemia (CLL). These can be caused by …
Long telomeres and cancer risk: the price of cellular immortality.
McNally EJ, Luncsford PJ, Armanios M. McNally EJ, et al. J Clin Invest. 2019 Aug 5;129(9):3474-3481. doi: 10.1172/JCI120851. eCollection 2019 Aug 5. J Clin Invest. 2019. PMID: 31380804 Free PMC article. Review.
We have hypothesized that these cancers represent a long telomere syndrome that is associated with a high penetrance of cutaneous melanoma and chronic lymphocytic leukemia. In this Review, we will synthesize the clinical and human genetic observatio …
We have hypothesized that these cancers represent a long telomere syndrome that is associated with a high penetrance of cutaneous mel …
Primary cutaneous lymphomas in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): A series of 12 cases.
Liu YA, Finn AJ, Subtil A. Liu YA, et al. J Cutan Pathol. 2021 May;48(5):617-624. doi: 10.1111/cup.13956. Epub 2021 Jan 23. J Cutan Pathol. 2021. PMID: 33415780
BACKGROUND: Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) is associated with an increased risk of a second malignancy. ...Demographic data, clinical information, and histopathology from 31 biopsies were recorded. Cases of secondary …
BACKGROUND: Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) is associated with an increased ri …
Melanoma and CLL co-occurrence and survival: role of KC history.
Zhao Y, Amorrortu RP, Stewart SC, Ghia KM, Williams VL, Sondak VK, Tsai KY, Pinilla-Ibarz J, Chavez JC, Rollison DE. Zhao Y, et al. BMC Cancer. 2023 Nov 9;23(1):1084. doi: 10.1186/s12885-023-11573-z. BMC Cancer. 2023. PMID: 37946198 Free PMC article.
BACKGROUND: Survival following melanoma and chronic lymphocytic leukemia (CLL) have both been individually associated with previous history of non-melanoma skin cancers (specifically keratinocyte carcinomas [KC]). ...A nested case-control study comparing pati …
BACKGROUND: Survival following melanoma and chronic lymphocytic leukemia (CLL) have both been individually associated w …
Detailing the epidemiological and clinical characteristics of chronic lymphocytic leukaemia in Portugal-Results from a population-based cancer registry cohort study.
Cardoso Borges F, Ramos A, Lourenço A, Gomes da Silva M, Miranda A; ROR-Sul network. Cardoso Borges F, et al. PLoS One. 2021 Oct 8;16(10):e0258423. doi: 10.1371/journal.pone.0258423. eCollection 2021. PLoS One. 2021. PMID: 34624053 Free PMC article.
BACKGROUND: Chronic lymphocytic leukaemia (CLL) is the most common leukaemia among adults in western countries. ...Five-year overall survival (OS) rate was 70.53% (95%CI 66.31-74.34) and age, lactate dehydrogenase, Binet stage and a 5 Charlson comorbidity ind …
BACKGROUND: Chronic lymphocytic leukaemia (CLL) is the most common leukaemia among adults in western countries. ...Five …
Targeting MDM4 as a Novel Therapeutic Approach for Hematologic Malignancies.
Cao L, Fan L, Xu W, Li JY. Cao L, et al. Curr Cancer Drug Targets. 2015;15(9):769-80. doi: 10.2174/156800961509151110124616. Curr Cancer Drug Targets. 2015. PMID: 26567881 Review.
It has been reported that frequent inactivation of p53 was observed in numerous human cancers including hematologic malignancies. MDM4, the newly discovered modulator of p53 protein, is frequently amplified in various solid tumors such as cutaneous melanoma, retinob …
It has been reported that frequent inactivation of p53 was observed in numerous human cancers including hematologic malignancies. MDM …
Prognostic and clinicopathological significance of PD-1/PD-L1 expression in the tumor microenvironment and neoplastic cells for lymphoma.
Xie M, Huang X, Ye X, Qian W. Xie M, et al. Int Immunopharmacol. 2019 Dec;77:105999. doi: 10.1016/j.intimp.2019.105999. Epub 2019 Nov 6. Int Immunopharmacol. 2019. PMID: 31704289 Review.
Increased infiltration of PD-1+ tumor-infiltrating lymphocytes (TILs) is a favorable prognostic factor in diffuse large B-cell lymphoma (DLBCL) but not in Hodgkin's lymphoma (HL). Higher numbers of PD-1+ TILs were observed in follicular lymphoma (FL) than in …
Increased infiltration of PD-1+ tumor-infiltrating lymphocytes (TILs) is a favorable prognostic factor in diffuse large B-cell …
Mutual Risks of Cutaneous Melanoma and Specific Lymphoid Neoplasms: Second Cancer Occurrence and Survival.
Herr MM, Schonfeld SJ, Dores GM, Withrow DR, Tucker MA, Curtis RE, Morton LM. Herr MM, et al. J Natl Cancer Inst. 2018 Nov 1;110(11):1248-1258. doi: 10.1093/jnci/djy052. J Natl Cancer Inst. 2018. PMID: 29659938 Free PMC article.
RESULTS: Among 151 949 one-or-more-year survivors of first primary LN, second primary CM risk was statistically significantly elevated after chronic lymphocytic leukemia/small lymphocytic lymphoma (SIR = 1.96, 95% confidence interval [CI] = 1.74 to 2.2 …
RESULTS: Among 151 949 one-or-more-year survivors of first primary LN, second primary CM risk was statistically significantly elevated after …
114 results